These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6012465)

  • 21. [Natulan (experimental and clinical data on its antitumor effect)].
    Brodskaia NA
    Vopr Onkol; 1972; 18(11):101-9. PubMed ID: 4566561
    [No Abstract]   [Full Text] [Related]  

  • 22. [Leurosine, the 3d alkaloid from Vinca rosea, in the treatmen t of Hodgkin's disease, acute lymphoblastic leukemia and lymphoblastosarcoma].
    Schneider M; Band P; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2952-4. PubMed ID: 4292621
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical and lymphographic checking of progress in lymphogranulomatosis and reticulum cell sarcoma under treatment with Natulan].
    Obrecht P; Strickstrock KH; Weissleder H
    Eur J Cancer (1965); 1966 Feb; 2(1):59-68. PubMed ID: 5336132
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
    de Oliveira HP; Atten MT
    Hospital (Rio J); 1966 Sep; 70(3):651-69. PubMed ID: 4867575
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
    Quattrin N; Montuori R
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
    Hosein PJ; Craig MD; Tallman MS; Boccia RV; Hamilton BL; Lewis JJ; Lossos IS
    Am J Hematol; 2012 Jan; 87(1):111-4. PubMed ID: 22081459
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of a methyl hydrazine derivative in the treatment of Hodgkin's disease].
    Hollard D; Schaerrer R
    Lyon Med; 1966 Apr; 215(17):1167-74. PubMed ID: 5930371
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of treatment of malignant granuloma with Natulan Roche].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1968 Aug; 21(16):1417-9. PubMed ID: 5699696
    [No Abstract]   [Full Text] [Related]  

  • 30. [Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
    Dubois-Ferrière H
    Schweiz Med Wochenschr; 1967 Nov; 97(44):1478-9. PubMed ID: 5631771
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytotoxic agents in the treatment of malignant disease.
    Br Med J; 1968 Nov; 4(5628):438-9. PubMed ID: 4972069
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of treatment of Hodgkin's disease in children with cytostatic drugs].
    Sroczyńska M; Miller W; Górniak J; Maszewska-Kuźniarz K
    Pediatr Pol; 1971 Feb; 46(2):189-92. PubMed ID: 5553864
    [No Abstract]   [Full Text] [Related]  

  • 33. Hodgkin's disease and some solid tumours.
    Jelliffe AM
    Proc R Soc Med; 1966 Dec; 59(12):1261-8. PubMed ID: 5955849
    [No Abstract]   [Full Text] [Related]  

  • 34. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
    Laricchia-Robbio L; Moscato S; Genua A; Liberati AM; Revoltella RP
    J Cell Physiol; 1997 Nov; 173(2):219-26. PubMed ID: 9365526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New chemotherapeutic agents in Hodgkin's disease.
    Hall TC
    Cancer Res; 1966 Jun; 26(6):1297-302. PubMed ID: 5947354
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ferritin in the serum of patients with Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma and polycythemia vera].
    Kardaszewicz S; Rusinowska Z; Skałba P; Kokocińska D
    Pol Tyg Lek; 1988 Feb; 43(7):214-6. PubMed ID: 3405891
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of bortezomib in B-cell non-Hodgkin's lymphoma.
    Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trial treatment of generalized Hodgkin's disease by multiple chemotherapy].
    Amiel JL; Berumen L; Schwarzenberg L; Schneider M; Cattan A; Schlumberger JR; Mathé G
    Sem Hop; 1966 Nov; 42(49):2970-4. PubMed ID: 4292625
    [No Abstract]   [Full Text] [Related]  

  • 39. [First clinical experiences with methylhydrazine in treatment of malignant lymphogranuloma].
    Fazio M; Cavallero P; Sartoris S; Vergnano F; Pegoraro L
    Minerva Med; 1965 Dec; 56(99):4338-43. PubMed ID: 5323491
    [No Abstract]   [Full Text] [Related]  

  • 40. [Methylhydrazine in the treatment of Hodgkin's disease].
    Sartoris S; Bachi C; Blefari D; Cavallero P; Vergnano F; Fazio M
    Minerva Med; 1968 Jan; 59(7):296-300. PubMed ID: 5638686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.